After prior trial flop, EyePoint's Duravyu bounces back with promising data in DME 0 28.10.2024 18:45 Fiercepharma.com After prior trial flop, EyePoint's Duravyu bounces back with promising data in DME fkansteiner Mon, 10/28/2024 - 11:45 Moscow.media Частные объявления сегодня Rss.plus Все новости за 24 часа
